2,3-Dihydrobenzofuran

2,3-Dihydrobenzofuran (CAS No.: 496-16-2) is a biologically active coumaran scaffold widely utilized in biomedical research as a pharmacophore present in diverse natural products and synthetic compounds with neuroactive and antiparasitic properties. This small molecule has been characterized as an acetylcholinesterase inhibitor, implicating it in cholinergic signaling modulation and making it relevant for studies in neurobiology and neurodegenerative disease mechanisms. In addition, it exhibits antileishmanial activity, which is thought to be mediated in part through the activation and functional modulation of macrophages, highlighting its role in host-directed immune responses and innate antimicrobial defense pathways. Experimental observations also suggest cytotoxic effects in cancer cell models, with activity reported at low micromolar concentrations, supporting its potential utility in oncology-related screening efforts. Owing to its immunomodulatory and antiparasitic properties, 2,3-dihydrobenzofuran is frequently employed in in vitro cellular assays and exploratory in vivo studies aimed at elucidating macrophage-mediated mechanisms, evaluating antiparasitic drug candidates, and investigating cholinesterase inhibition. The concentrations or dosing regimens applied in such studies typically vary depending on the specific experimental design and biological system under investigation, and the compound is also of interest as a lead structure in the development of biopesticides and novel therapeutic agents.